Atlas Venture Opportunity Fund I, L.P.
CIK 1759241 · last filed 2022-11-01
Atlas Venture Opportunity Fund I, L.P. is a corporate insider who has filed 74 SEC Form 4 insider transactions across 6 companies since 2019. The most recent filing, for DYN, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$54.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $744.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$744.22M
6
74
-$54.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | 10%+ Owner | 6,784,648 | $109.62 | $743.73M | -$52.41M | 1 | 2022-11-01 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | 10%+ Owner | 793,116 | $21.53 | $17.08M | $0 | 1 | 2022-07-06 |
| XLO | 10%+ Owner | 52,567 | $9.18 | $482.6K | $6.00M | 1 | 2021-10-26 |
| Generation Bio Co. (GBIO) Delisted | 10%+ Owner | 711,194 | $5.34 | $3.80M | -$8.24M | 1 | 2021-09-29 |
| ImageneBio, Inc. (IKNA) Delisted | 10%+ Owner | 241,801 | $17.16 | $4.15M | $0 | 1 | 2021-04-01 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 404,079 | $54.65 | $22.08M | $0 | 2 | 2020-02-10 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | DYN | Notice (144) | −60,858 | -$1.39M | EDGAR |
| 2026-07-06 | DYN | Notice (144) | −100,019 | -$2.31M | EDGAR |
| 2026-06-29 | KYMR | Notice (144) | −10,473 | -$1.13M | EDGAR |
| 2026-06-29 | DYN | Notice (144) | −40,702 | -$852.3K | EDGAR |
| 2026-06-26 | DYN | Notice (144) | −64,411 | -$1.33M | EDGAR |
| 2026-06-26 | KYMR | Notice (144) | −57,451 | -$6.69M | EDGAR |
| 2026-06-25 | DYN | Notice (144) | −5,019 | -$102.0K | EDGAR |
| 2026-06-25 | KYMR | Notice (144) | −67,329 | -$6.72M | EDGAR |
| 2026-06-24 | DYN | Notice (144) | −19,973 | -$404.7K | EDGAR |
| 2026-06-24 | KYMR | Notice (144) | −16,542 | -$1.63M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.